ARTICLE | Financial News
Evelo raises $85M in IPO
May 11, 2018 6:37 PM UTC
Microbiome company Evelo Biosciences Inc. (NASDAQ:EVLO) raised on May 8 $85 million through the sale of 5.3 million shares at $16 in an IPO underwritten by Morgan Stanley, Cowen, BMO Capital Markets and JMP Securities.
Evelo priced the offering at the midpoint of its proposed range of $15-$17. The price valued the company at $509.9 million...
BCIQ Company Profiles